参考文献/References:
[1] 中华医学会神经病学分会帕金森病及运动障碍学组,中国医师协会神经内科医师分会帕金森病及运动障碍学组.中国帕金森病治疗指南(第四版)[J].中华神经科杂志,2020,53(12):973-986.
[2] Tysnes OB,Storstein A.Epidemiology of Parkinson's disease[J].J Neural Transm(Vienna),2017,124(8):901-905.
[3] 中华医学会神经病学分会帕金森病及运动障碍学组,中国医师协会神经内科医师分会帕金森病及运动障碍病专业委员会.帕金森病前驱期诊断研究标准中国专家共识[J].中华老年医学杂志,2019,38(8):825-831.
[4] Hayes MT.Parkinson's disease and parkinsonism[J].Am J Med,2019,132(7):802-807.
[5] Armstrong MJ,Okun MS.Diagnosis and treatment of parkinson disease:A review[J].JAMA,2020,323(6):548-560.
[6] 辛陈琦,张承斌,李 林.帕金森病发病机制与治疗研究进展[J].医学研究生学报,2019,32(6):646-651.
[7] Fox SH,Katzenschlager R,Lim SY,et al.International Parkinson and movement disorder society evidence-based medicine review:Update on treatments for the motor symptoms of Parkinson's disease[J].Mov Disord,2018,33(8):1248-1266.
[8] 王 超,裴 媛.帕金森病的早期治疗观察与临床分析[J].中外医学研究,2020,18(7):143-144.
[9] 李广义,程起元.弥散加权成像(DWI)技术及其临床应用[J].中国医疗器械信息,2015,21(1):12-16.
[10] Filograna L,Magarelli N,Cellini F,et al.Diffusion weighted imaging(DWI)and apparent diffusion coefficient(ADC)values for detection of malignant vertebral bone marrow lesions[J].Eur Rev Med Pharmacol Sci,2018,22(3):590-597.
[11] Norris CD,Quick SE,Parker JG,et al.Diffusion MR imaging in the head and neck:Principles and applications[J].Neuroimaging Clin N Am,2020,30(3):261-282.
[12] 金 玮,李跃华,李 斌,等.磁共振弥散张量成像和纤维束密度成像在中枢神经系统的研究进展[J].中国医疗器械杂志,2019,43(5):352-354,368.
[13] 刘翠兰,黄小华,刘梦苓,等.体素内不相干运动扩散加权成像在腹部中的研究进展[J].川北医学院学报,2017,32(3):466-470.
[14] Tae WS,Ham J,Pyun SB,et al.Current clinical applications of diffusion-tensor imaging in neurological disorders[J].J Clin Neurol,2018,14(2):129-140.
[15] Edwards LJ,Pine KJ,Ellerbrock I,et al.NODDI-DTI:Estimating neurite orientation and dispersion parameters from a diffusion tensor in healthy white matter[J].Front Neurosci,2017,11:720.
[16] 唐丽媛,刘钰鑫,邵 毅.弥散张量成像(DTI)在眼科临床的应用[J].眼科新进展,2018,38(9):887-891.
[17] 吴佳芮.磁共振弥散张量成像检查在帕金森病诊断中的价值[J].中国民康医学,2020,32(12):103-105.
[18] 陈 晨.帕金森病患者脑白质微结构改变的DTI评价[D].郑州:郑州大学,2019.
[19] Minett T,Su L,Mak E,et al.Longitudinal diffusion tensor imaging changes in early Parkinson's disease:ICICLE-PD study[J].J Neurol,2018,265(7):1528-1539.
[20] 张 亚,陈博宇,商秀丽,等.早期帕金森病患者脑白质损害的扩散张量成像研究[J].放射学实践,2017,32(12):1248-1251.
[21] Bergamino M,Keeling EG,Mishra VR,et al.Assessing white matter pathology in early-stage parkinson disease using diffusion MRI:A systematic review[J].Front Neurol,2020,11:314.
[22] 宋建萍.早期帕金森病大脑白质DTI基于纤维束追踪空间统计分析的研究[D].昆明:昆明医科大学,2016.
[23] Atkinson-Clement C,Pinto S,Eusebio A,et al.Diffusion tensor imaging in Parkinson's disease:Review and meta-analysis[J].Neuroimage Clin,2017,16:98-110.
[24] Sanjari MH,Dolatshahi M,Mohebi F,et al.Structural white matter alterations as compensatory mechanisms in Parkinson's disease:A systematic review of diffusion tensor imaging studies[J].J Neurosci Res,2020,98(7):1398-1416.
[25] 高亚军,刘 峰,高晓嵘.脑白质微结构改变与帕金森病认知功能损害的相关性[J].陕西医学杂志,2016,45(4):448-449.
[26] Knossalla F,Kohl Z,Winkler J,et al.High-resolution diffusion tensor-imaging indicates asymmetric microstructural disorganization within substantia nigra in early Parkinson's disease[J].J Clin Neurosci,2018,50:199-202.
[27] Wang J,Yang QX,Sun X,et al.MRI evaluation of asymmetry of nigrostriatal damage in the early stage of early-onset Parkinson's disease[J].Parkinsonism Relat Disord,2015,21(6):590-596.
[28] 梁红红.帕金森病伴嗅觉障碍患者的弥散张量成像研究[D].郑州:郑州大学,2019.
[29] Nigro P,Chiappiniello A,Simoni S,et al.Changes of olfactory tract in Parkinson's disease:A DTI tractography study[J].Neuroradiology,2021,63(2):235-242.
[30] Li Z,Liu W,Xiao C,et al.Abnormal white matter microstructures in Parkinson's disease and comorbid depression:A whole-brain diffusion tensor imaging study[J].Neurosci Lett,2020,735:135238.
[31] Hu X,Qian L,Zhang Y,et al.Topological changes in white matter connectivity network in patients with Parkinson's disease and depression[J].Brain Imaging Behav,2020,14(6):2559-2568.
[32] Gorges M,Müller HP,Liepelt-Scarfone I,et al.Structural brain signature of cognitive decline in Parkinson's disease:DTI-based evidence from the LANDSCAPE study[J].Ther Adv Neurol Disord,2019,12:1278065015.
[33] Bledsoe IO,Stebbins GT,Merkitch D,et al.White matter abnormalities in the corpus callosum with cognitive impairment in Parkinson disease[J].Neurology,2018,91(24):e2244-e2255.
[34] Alzaid H,Ethofer T,Hobert MA,et al.Distinct relationship between cognitive flexibility and white matter integrity in individuals at risk of Parkinson's disease[J].Front Aging Neurosci,2020,12:250.
[35] Maehara M.Development of voxel-based optimization diffusion kurtosis imaging(DKI)and comparison with conventional DKI[J].Radiol Phys Technol,2019,12(3):290-298.
[36] 李 燕,司海娜,田玉玲,等.扩散峰度成像在帕金森病早期诊断中的应用价值探讨[J].磁共振成像,2019,10(7):486-490.
[37] 李东升,马建军,李 学,等.磁共振弥散张量及磁敏感加权成像对早期原发性单侧症状帕金森病的诊断价值[J].中国实用神经疾病杂志,2018,21(19):2143-2148.
[38] Qiao PF,Shi F,Jiang MF,et al.Application of high-field magnetic resonance imaging in Parkinson's disease[J].Exp Ther Med,2017,13(5):1665-1670.
[39] 孙崎元.多种磁共振成像技术对早期帕金森病患者脑灰质核团应用价值的研究[D].长春:北华大学,2019.
[40] Eduardo Flores-Alvarez EARP.Correlations between DTI-derived metrics and MRS metabolites in tumour regions of glioblastoma:A pilot study[J].Radiology and oncology,2020,54(4):394-408.
[41] Partridge L,Deelen J,Slagboom PE.Facing up to the global challenges of ageing[J].Nature,2018,561(7721):45-56.
相似文献/References:
[1]李会琪,王海过,何剑波,等.同型半胱氨酸与帕金森病认知损害的相关性研究[J].陕西医学杂志,2016,(10):1346.
[2]徐胜男,马贺骥.磁共振多模态成像在超急性期大面积脑梗死诊断中的价值研究[J].陕西医学杂志,2021,50(8):995.[doi:DOI:10.3969/j.issn.1000-7377.2021.08.023]
XU Shengnan,MA Heji.Value of multi-modal magnetic resonance imaging in diagnosis of hyperacute massive cerebral infarction[J].,2021,50(10):995.[doi:DOI:10.3969/j.issn.1000-7377.2021.08.023]
[3]王 丰,李 莎,胡赛琴,等.基于弥散张量成像主观认知下降患者脑效应机制研究进展[J].陕西医学杂志,2022,51(1):117.[doi:DOI:10.3969/j.issn.1000-7377.2022.01.029]
WANG Feng,LI Sha,HU Saiqin,et al.Research progress of brain effect mechanism in patients with subjective cognitive decline based on diffusion tensor imaging[J].,2022,51(10):117.[doi:DOI:10.3969/j.issn.1000-7377.2022.01.029]
[4]赵晓娟,权青云,孟宏涛,等.α-突触核蛋白与帕金森病伴发快速眼动期睡眠行为障碍相关性研究[J].陕西医学杂志,2022,51(2):191.[doi:DOI:10.3969/j.issn.1000-7377.2022.02.014]
ZHAO Xiaojuan,QUAN Qingyun,MENG Hongtao,et al.Relationship between α-synuclein and rapid eye movement sleep behavior disorder in Parkinson's disease[J].,2022,51(10):191.[doi:DOI:10.3969/j.issn.1000-7377.2022.02.014]
[5]刘 斌,杨浩辉,任 伯,等.丁苯酞联合美多芭对帕金森病伴抑郁模型小鼠黑质纹状体Ⅱ型髓系细胞触发受体及小胶质细胞炎症标志物表达的影响[J].陕西医学杂志,2022,51(12):1477.[doi:DOI:10.3969/j.issn.1000-7377.2022.12.003]
LIU Bin,YANG Haohui,REN Bo,et al.Effects of butylphthalide combined with medoba on expression of TREM2 and microglia inflammatory markers in substantia nigra striatum of Parkinson's disease with depression model mice[J].,2022,51(10):1477.[doi:DOI:10.3969/j.issn.1000-7377.2022.12.003]
[6]张 强,袁 婕,董晓云,等.磁共振弥散张量成像在无症状性腔隙性脑梗死患者认知障碍中的应用研究[J].陕西医学杂志,2023,52(1):57.[doi:DOI:10.3969/j.issn.1000-7377.2023.01.013]
ZHANG Qiang,YUAN Jie,DONG Xiaoyun,et al.Application of diffusion tensor imaging in cognitive impairment of patients with asymptomatic lacunar infarction[J].,2023,52(10):57.[doi:DOI:10.3969/j.issn.1000-7377.2023.01.013]
[7]高继英,石代乐,王 刚.长链非编码RNA NORAD过表达通过靶向调控miR-132-5p/Bcl-2改善MPP+诱导的帕金森细胞模型损伤实验研究[J].陕西医学杂志,2023,52(4):363.[doi:DOI:10.3969/j.issn.1000-7377.2023.04.001]
GAO Jiying,SHI Daile,WANG Gang.LncRNA NORAD overexpression improves MPP+ induced Parkinson cell model injury by targeting miR-132-5p/Bcl-2[J].,2023,52(10):363.[doi:DOI:10.3969/j.issn.1000-7377.2023.04.001]
[8]朱雪莲,乔 飞,穆耶赛尔·马合木提,等.帕金森病患者血铜蓝白水平与黑质铁沉积相关性分析[J].陕西医学杂志,2024,(7):940.[doi:DOI:10.3969/j.issn.1000-7377.2024.07.016]
ZHU Xuelian,QIAO Fei,MUYESAIR Mahemuti,et al.Correlation analysis between ceruloplasmin level and iron deposition in substantia nigra in patients with Parkinson's disease[J].,2024,(10):940.[doi:DOI:10.3969/j.issn.1000-7377.2024.07.016]